These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 6248211

  • 1. Comparative effects of vindesine, vinblastine, and vincristine on mitotic arrest and hormonal response of L1210 leukemia cells.
    Howard SM, Theologides A, Sheppard JR.
    Cancer Res; 1980 Aug; 40(8 Pt 1):2695-700. PubMed ID: 6248211
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
    Jordan MA, Himes RH, Wilson L.
    Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
    [Abstract] [Full Text] [Related]

  • 3. Comparative cell killing and kinetic effects of vincristine or vindesine in mammalian cell lines.
    Hill BT, Whelan RD.
    J Natl Cancer Inst; 1981 Aug; 67(2):437-43. PubMed ID: 6943380
    [Abstract] [Full Text] [Related]

  • 4. The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis.
    McGown AT, Poppitt DG, Swindell R, Fox BW.
    Cancer Chemother Pharmacol; 1984 Aug; 13(1):47-53. PubMed ID: 6733842
    [Abstract] [Full Text] [Related]

  • 5. Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia.
    Chello PL, Sirotnak FM.
    Cancer Treat Rep; 1981 Aug; 65(11-12):1049-53. PubMed ID: 7296551
    [Abstract] [Full Text] [Related]

  • 6. The action of two Vinca alkaloids on B16 melanoma in vitro.
    Donoso JA, Himes RH.
    Cancer Biochem Biophys; 1984 Jun; 7(2):133-45. PubMed ID: 6467174
    [Abstract] [Full Text] [Related]

  • 7. Cellular pharmacokinetics of vinblastine and other vinca alkaloids in MO4 cells.
    Van Belle SJ, De Smet MC, De Mey JE, Storme GA.
    Anticancer Res; 1991 Jun; 11(1):465-71. PubMed ID: 2018383
    [Abstract] [Full Text] [Related]

  • 8. Cross-resistance of cultured murine leukemia vincristine-resistant P388 cells to vinblastine, vindesine, and bis (N-ethylidene vindesine) disulfide, disulfate.
    Wilkoff LJ, Dulmadge EA.
    J Natl Cancer Inst; 1982 Jun; 68(6):1023-6. PubMed ID: 6953266
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of murine CFU-C by vindesine: restoration of colony growth by colony stimulating factor.
    Pigoli G, Mangoni L, Caramatti C, Degliantoni G, Rizzoli V.
    Int J Cell Cloning; 1983 Jul; 1(3):142-50. PubMed ID: 6609213
    [Abstract] [Full Text] [Related]

  • 10. Collateral sensitivity of a methotrexate-resistant L1210 cell line to the vinca alkaloids.
    Poppitt DG, McGown AT, Fox BW.
    Cancer Chemother Pharmacol; 1984 Jul; 13(1):43-6. PubMed ID: 6733841
    [Abstract] [Full Text] [Related]

  • 11. In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence.
    Binet S, Fellous A, Lataste H, Krikorian A, Couzinier JP, Meininger V.
    Semin Oncol; 1989 Apr; 16(2 Suppl 4):5-8. PubMed ID: 2652320
    [Abstract] [Full Text] [Related]

  • 12. Flow cytometric evaluation of the cell cycle perturbations induced by S12363, a new vinca alkaloid derivative.
    Leonce S, Anstett M, Combe-Perez V, Pierre A.
    Anticancer Drugs; 1990 Dec; 1(2):179-83. PubMed ID: 2131051
    [Abstract] [Full Text] [Related]

  • 13. Use of snail neurons in developing quantitative ultrastructural parameters for neurotoxic side effects of Vinca antitumor agents.
    Müller LJ, Moorer-van Delft CM, Zijl R, Roubos EW.
    Cancer Res; 1990 Mar 15; 50(6):1924-8. PubMed ID: 2407348
    [Abstract] [Full Text] [Related]

  • 14. Vinca-23-oyl amino acid derivatives: as new anticancer agents (review).
    Bhushana Rao KS, Collard MP, Trouet A.
    Anticancer Res; 1985 Mar 15; 5(4):379-86. PubMed ID: 3898995
    [Abstract] [Full Text] [Related]

  • 15. Effects of alpha-difluoromethylornithine alone and combined with adriamycin or vindesine on L1210 leukemia in mice, EMT6 solid tumors in mice, and solid tumors induced by injection of hepatoma tissue culture cells in rats.
    Bartholeyns J, Koch-Weser J.
    Cancer Res; 1981 Dec 15; 41(12 Pt 1):5158-61. PubMed ID: 6796266
    [Abstract] [Full Text] [Related]

  • 16. Identification of Vinca alkaloid acceptors in P388 murine leukemia cells with a photoactive analogue of vinblastine.
    Safa AR, Glover CJ, Felsted RL.
    Cancer Res; 1987 Oct 01; 47(19):5149-54. PubMed ID: 3621200
    [Abstract] [Full Text] [Related]

  • 17. Differential activity of vincristine and vinblastine against cultured cells.
    Ferguson PJ, Phillips JR, Selner M, Cass CE.
    Cancer Res; 1984 Aug 01; 44(8):3307-12. PubMed ID: 6744266
    [Abstract] [Full Text] [Related]

  • 18. Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.
    Sweeney MJ, Boder GB, Cullinan GJ, Culp HW, Daniels WD, Dyke RW, Gerzon K, McMahon RE, Nelson RL, Poore GA, Todd GC.
    Cancer Res; 1978 Sep 01; 38(9):2886-91. PubMed ID: 679195
    [No Abstract] [Full Text] [Related]

  • 19. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
    Kruczynski A, Barret JM, Etiévant C, Colpaert F, Fahy J, Hill BT.
    Biochem Pharmacol; 1998 Mar 01; 55(5):635-48. PubMed ID: 9515574
    [Abstract] [Full Text] [Related]

  • 20. Kinetic analysis in living cells of the inhibition of the P-glycoprotein-mediated efflux of anthracyclines by vinca alkaloids.
    Pereira E, Tarasiuk J, Garnier-Suillerot A.
    Chem Biol Interact; 1998 Jul 03; 114(1-2):61-76. PubMed ID: 9744556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.